What is the projected market valuation of the US Laboratory Information Management Systems market by 2035?

The projected market valuation of the US LIMS market is expected to reach 1341.6 USD Million by 2035. Read More

What was the overall market valuation of the US LIMS market in 2024?

The overall market valuation of the US LIMS market was 668.88 USD Million in 2024. Read More

What is the expected CAGR for the US LIMS market during the forecast period 2025 - 2035?

The expected CAGR for the US LIMS market during the forecast period 2025 - 2035 is 6.53%. Read More

Which companies are considered key players in the US LIMS market?

Key players in the US LIMS market include Thermo Fisher Scientific, LabWare, STARLIMS, PerkinElmer, Abbott Laboratories, Agilent Technologies, LabVantage Solutions, Waters Corporation, and IDBS. Read More

What are the primary applications of LIMS in the US market?

The primary applications of LIMS in the US market include Clinical Research, Quality Control, Drug Development, Environmental Testing, and Biobanking. Read More

How does the deployment type affect the US LIMS market?

The US LIMS market is segmented by deployment type into On-Premise, Cloud-Based, and Hybrid, with Cloud-Based solutions projected to generate between 300.0 and 600.0 USD Million. Read More

What is the US market size for the pharmaceutical sector within the US LIMS market?

The US market size for the pharmaceutical sector within the US LIMS market is projected to range from 200.0 to 400.0 USD Million. Read More

What functionalities are most valued in the US LIMS market?

The most valued functionalities in the US LIMS market include Compliance Management, Data Management, and Workflow Management, with Compliance Management expected to generate between 200.0 and 391.6 USD Million. Read More

What user types are predominant in the US LIMS market?

Predominant user types in the US LIMS market include Laboratory Technicians, Researchers, Quality Assurance Professionals, and Laboratory Managers. Read More

What is the expected growth trend for the US LIMS market in the coming years?

The US LIMS market is anticipated to experience steady growth, with a projected valuation increase from 668.88 USD Million in 2024 to 1341.6 USD Million by 2035. Read More

US Laboratory Information Management Systems Market

ID: MRFR/HC/51263-HCR

200 Pages

Vikita Thakur

Last Updated: April 27, 2026

US Laboratory Information Management Systems LIMS Market Research Report By Deployment Type (On-Premise, Cloud-Based, Hybrid), By End-user (Pharmaceuticals, Biotechnology, Clinical Research Organizations, Environmental Testing, Food and Beverage), By Functionality (Sample Management, Workflow Management, Data Management, Reporting and Analytics), and By Product Type (Standalone LIMS, Integrated LIMS, Modular LIMS) - Growth & Industry Forecast 2025 To 2035

US Laboratory Information Management Systems Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Million) | |
  1. 4.1.1 Clinical Research | |
  2. 4.1.2 Quality Control | |
  3. 4.1.3 Drug Development | |
  4. 4.1.4 Environmental Testing | |
  5. 4.1.5 Biobanking |
2. 4.2 Healthcare, BY End Use (USD Million) | |
  1. 4.2.1 Pharmaceuticals | |
  2. 4.2.2 Biotechnology | |
  3. 4.2.3 Clinical Laboratories | |
  4. 4.2.4 Academic Research | |
  5. 4.2.5 Contract Research Organizations |
3. 4.3 Healthcare, BY Deployment Type (USD Million) | |
  1. 4.3.1 On-Premise | |
  2. 4.3.2 Cloud-Based | |
  3. 4.3.3 Hybrid |
4. 4.4 Healthcare, BY Functionality (USD Million) | |
  1. 4.4.1 Sample Management | |
  2. 4.4.2 Data Management | |
  3. 4.4.3 Workflow Management | |
  4. 4.4.4 Reporting | |
  5. 4.4.5 Compliance Management |
5. 4.5 Healthcare, BY User Type (USD Million) | |
  1. 4.5.1 Laboratory Technicians | |
  2. 4.5.2 Researchers | |
  3. 4.5.3 Quality Assurance Professionals | |
  4. 4.5.4 Laboratory Managers 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Thermo Fisher Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 LabWare (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 STARLIMS (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 PerkinElmer (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Abbott Laboratories (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Agilent Technologies (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 LabVantage Solutions (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Waters Corporation (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 IDBS (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY APPLICATION |
6. 6.3 US MARKET ANALYSIS BY END USE |
7. 6.4 US MARKET ANALYSIS BY DEPLOYMENT TYPE |
8. 6.5 US MARKET ANALYSIS BY FUNCTIONALITY |
9. 6.6 US MARKET ANALYSIS BY USER TYPE |
10. 6.7 KEY BUYING CRITERIA OF HEALTHCARE |
11. 6.8 RESEARCH PROCESS OF MRFR |
12. 6.9 DRO ANALYSIS OF HEALTHCARE |
13. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
14. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
15. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE |
16. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
17. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
18. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE) |
19. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million) |
20. 6.17 HEALTHCARE, BY DEPLOYMENT TYPE, 2024 (% SHARE) |
21. 6.18 HEALTHCARE, BY DEPLOYMENT TYPE, 2024 TO 2035 (USD Million) |
22. 6.19 HEALTHCARE, BY FUNCTIONALITY, 2024 (% SHARE) |
23. 6.20 HEALTHCARE, BY FUNCTIONALITY, 2024 TO 2035 (USD Million) |
24. 6.21 HEALTHCARE, BY USER TYPE, 2024 (% SHARE) |
25. 6.22 HEALTHCARE, BY USER TYPE, 2024 TO 2035 (USD Million) |
26. 6.23 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
27. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
28. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million) | |
  2. 7.2.2 BY END USE, 2026-2035 (USD Million) | |
  3. 7.2.3 BY DEPLOYMENT TYPE, 2026-2035 (USD Million) | |
  4. 7.2.4 BY FUNCTIONALITY, 2026-2035 (USD Million) | |
  5. 7.2.5 BY USER TYPE, 2026-2035 (USD Million) |
29. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
30. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

Clinical Research
Quality Control
Drug Development
Environmental Testing
Biobanking

Healthcare By End Use (USD Million, 2026-2035)

Pharmaceuticals
Biotechnology
Clinical Laboratories
Academic Research
Contract Research Organizations

Healthcare By Deployment Type (USD Million, 2026-2035)

On-Premise
Cloud-Based
Hybrid

Healthcare By Functionality (USD Million, 2026-2035)

Sample Management
Data Management
Workflow Management
Reporting
Compliance Management

Healthcare By User Type (USD Million, 2026-2035)

Laboratory Technicians
Researchers
Quality Assurance Professionals
Laboratory Managers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓